Search results
SPARC Summary: Latest Updates and Details | India Infoline
India Infoline· 21 hours agoSun Pharma Advanced Research Company Ltd Summary: Check out the latest management information and corporate updates of SPARC at India Infoline
Central Travancore a sitting duck for avian flu
The Hindu· 2 days agoIt was just another day for Abraham Ouseph, who had taken his ducks to the Vilakkupadam paddy polder for foraging as usual. Ouseph hails from...
Norris ready to move on after talking through Austrian clash with Verstappen
Racer· 2 days agoLando Norris says he no longer believes Max Verstappen needs to apologize to him for the contact...
Shree Ganesh Remedies Ltd Director Discussions | India Infoline
India Infoline· 2 days agoYour directors have pleasure in presenting the 28th Annual Report of your Company together with the Audited Financial Statements for the year ended on 31st March, 2023. After all the financial ...
Lupin share price jumps 5% after Kotak upgrades stock to an add, raises fair value; here’s what the...
Livemint· 2 days agoLupin share price: Shares of pharmaceutical player Lupin jumped over 5 per cent in morning trade on...
Tech Mahindra Ltd Management Discussions | India Infoline
India Infoline· 2 days agoTech Mahindra Ltd Management Discussions: Check out the latest updates, and news about the Tech Mahindra management discussions at India Infoline
Sell Nifty IT on the rise; resistance at 38,350, check other details here
Business Standard India· 2 days agoThe Nifty IT Index is currently trading at 37,314.35. In the near term, the index appears to be...
Kargil War Heroes Reflect on Decisive Battles 25 Years Later
One India· 2 days agoOn the 25th anniversary of the Kargil War, heroes like Col. Balwan Singh recall the pivotal victories at Tololing and Tiger Hill that led to India's triumph.
Class action lawsuits are unicorn-like: Worthy but rare
Livemint· 3 days agoFurther, class action suits are often clothed as public interest litigation (PIL) under Articles 32...
Left in limbo: When pharma halts rare disease research
Pharmaceutical Technology· 3 days agoElpida aims to use any money it makes after paying the promissory notes to fund more programmes....